Drug Reference
Bifidobacterium animalis / Lactobacillus acidophilus
Available as
15000000000 UNT · Oral Capsule7500000000 UNT · Oral Capsule16000000000 UNT · Oral Capsule
Multi-ingredient product
Bifidobacterium AnimalisLactobacillus Acidophilus
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- BIOMEXA (LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM ANIMALIS LACTIS) CAPSULE [ONCORA PHARMA, LLC]
- NOVORA (LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM ANIMALIS) CAPSULE [BLUE HERON PHARMACEUTICALS, LLC]
- NEXIVA (LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM LACTIS) CAPSULE [BLUE HERON PHARMACEUTICALS, LLC]
- PRORIVA (LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM ANIMALIS LACTIS) CAPSULE [REDMONT PHARMACEUTICALS, LLC]
- RELIBIOTIC (LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM ANIMALIS LACTIS) CAPSULE [REDMONT PHARMACEUTICALS, LLC]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.